Consortium Nano4Tarmed is developing 2D nanoplatforms for active drug delivery and diagnosis of osteosarcoma.
Population growth is shrinking, mainly due to the overall fertility rate...
Dr Paul Roach, President of the UK Society for Biomaterials, outlines the aims of the organisation and explains what the biomaterials sector learnt from...
AIMed is a Marie Sklodowska-Curie Innovative Training Network (Horizon2020 MSCA-ITN) training 15 early-stage researchers to develop materials with antimicrobial properties suitable for use on...